跳至主要内容
临床试验/NCT02275650
NCT02275650已完成不适用

The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter

Joint Authority for Päijät-Häme Social and Health Care4 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2013年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
37
试验地点
4
主要终点
25(OH)D level

研究概览

简要总结

The investigators investigated the ability of narrowband ultraviolet B (nbUVB) treatment in the maintenance of vitamin D levels achieved during the summer in Finland. The investigators randomized 37 subjects into groups of 17 and 18 subjects. The other group received 2 standard erythema doses (SED) nbUVB exposure every other week until week 24, and serum 25(OH)D levels were measured at the onset and at weeks 6, 14, 20, 26 and 30. The control group was not illuminated and serum samples were analyzed correspondingly. Punch biopsies were taken at the onset and at week 14 for CYP27A1 and CYP27B1 enzyme expression level analyses.

详细描述

The investigators investigated the ability of narrowband ultraviolet B (nbUVB) treatment in the maintenance of vitamin D levels achieved during the summer in Finland. The investigators randomized 37 subjects into groups of 17 and 18 subjects. The other group received 2 standard erythema doses (SED) nbUVB exposure every other week until week 24, and serum 25(OH)D levels were measured at the onset and at weeks 6, 14, 20, 26 and 30. The control group was not illuminated and serum samples were analyzed correspondingly. 6mm punch biopsies were taken at the onset and at week 14 for CYP27A1 and CYP27B1 enzyme expression level analyses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age over 18
  • Fitzpacker's skin type II-IV

排除标准

  • age under 18
  • diseases that inhibit vitamin D metabolism or absorption
  • Fitzpacker's skin type I
  • history of skin cancer
  • vitamin D substitution 1 month before baseline or during study
  • sun holidays 1 month before baseline or during study

结局指标

主要结局

25(OH)D level

时间窗: up to 30 weeks

Serum 25(OH)D levels were measured at the onset and at weeks 6, 14, 20, 26 and 30.

次要结局

  • CYP27A1 and CYP27B1 enzyme expression levels(up to 14 weeks)

研究者

发起方
Joint Authority for Päijät-Häme Social and Health Care
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

The Role of Narrowband Ultraviolet B Exposure in the... | 临床试验